New article: MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia. https://t.co/fM1ySTHoju #AML #leukemia #hematology
925 followers
396 followers
RT @FrontOncology: New research: MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acut…
437 followers
RT @FrontOncology: New research: MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acut…
6,534 followers
New research: MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia: Acute myeloid leukemia (AML) requires refined risk stratification tools to drive decisions concerning… https://t.co/